Obstructive Pulmonary Disease clinical trials

Explore recruiting obstructive pulmonary disease clinical trials.

Recruiting obstructive pulmonary disease studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Obstructive Pulmonary Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigate the efficacy and safety of lunsekimig in adult participants with inadequately controlled chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype

Denmark, Sweden, Poland, Estonia, Portugal, Latvia +7 more

Phase II and Phase III (Integrated) EU CTIS Study details

A Phase 2b Randomized, Double-blind, Placebo-controlled, Parallel-Group Study to Assess Efficacy and Safety of Verekitug (UPB-101) in Participants with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Romania, Lithuania, Hungary, Spain, Bulgaria, Ireland +5 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigate the efficacy and safety of lunsekimig in adult participants with inadequately controlled chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype

Germany, Romania, Greece, Norway, Netherlands, Poland +4 more

Phase II and Phase III (Integrated) EU CTIS Study details

Beta-blockeRs tO patieNts with CHronIc Obstructive puLmonary diseasE (BRONCHIOLE)

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

A Double Blind, Multicentre, Randomised Three-Period, Three-Treatment, Cross-Over Study To Evaluate The Effect of BGF MDI, BFF MDI and Placebo MDI on Exercise Parameters In Participants with Chronic Obstructive Pulmonary Disease (ATHLOS)

Germany, Spain

Phase III and phase IV (Integrated) EU CTIS Study details

STOP-COPD Standard vs Targeted Oxygen Therapy Prehospital for Chronic Obstructive Pulmonary Disease

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Obstructive Pulmonary Disease trials by city

Obstructive Pulmonary Disease in Toronto Obstructive Pulmonary Disease in Vancouver Obstructive Pulmonary Disease in Montreal Obstructive Pulmonary Disease in Calgary Obstructive Pulmonary Disease in Edmonton Obstructive Pulmonary Disease in Ottawa Obstructive Pulmonary Disease in Winnipeg Obstructive Pulmonary Disease in Quebec City Obstructive Pulmonary Disease in Hamilton Obstructive Pulmonary Disease in Kitchener Obstructive Pulmonary Disease in London Obstructive Pulmonary Disease in Halifax Obstructive Pulmonary Disease in New York Obstructive Pulmonary Disease in Los Angeles Obstructive Pulmonary Disease in Chicago Obstructive Pulmonary Disease in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease